Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Practical Considerations for Patients with PAD Post-Revascularization

Access Activity

Overview / Abstract:

This vlog provides learners with the perspective of a leading vascular medicine expert, Dr. Anahita Dua, on recent advances and practical considerations for patients with PAD post-revascularization. Talking points include the latest approvals and evidence, real-world implications of these recent advances, and roles of the interdisciplinary team in the management of this patient population.

The purpose of this activity is to provide learners with a brief and engaging activity to provide current guidance and limitations with recommendations for patients with PAD post-revascularization, as well as understand the implications of recent evidence. Learners post-activity will be better able to tailor personalized treatment regimens for patients with PAD post-revascularization with respect to the latest clinical trial data and expert insights, and understand the role of the interdisciplinary team with post-revascularization care.

Expiration

Nov 09, 2022

Discipline(s)

Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

.25 AMA PRA Category 1 Credit(s)

Accreditation

ACCME

Presenters / Authors / Faculty

Anahita Dua, MBChB, MBA, MSc
Vascular Surgeon
Director MGH Vascular Lab
Co-Director of the MGH Vascular Lab
Associate Director of the MGH Wound Care Center
Massachusetts General Hospital
Boston, MA

Activity Specialities / Related Topics

Cardiology / Cardiovascular, Family Medicine, Primary Care

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Janssen Scientific Affairs, LLC.

Keywords / Search Terms

ACHL CME, CME/CE, Janssen, vlog, Anahita Dua, PAD, PAD Post-Revascularization, revascularization, Asymptomatic, Symptomatic, AHA, ACC, JACC, Lower-Extremity, CV, ischemic event, claudication, limb related, antiplatelet, anticoagulation, Warfarin, Aspirin, clopidogrel, Antithrombotic, CLTI, VOYAGER, DAPT, ACS, vascular, stroke, FDA, MOA, thrombin, inhibitor Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map